[Clinical efficacy of using amino acids in combination with anabolic steroids for the purpose of limiting the size of a myocardial infarct].
The authors report on the experience with amino acid drugs ( alvesin -new, aminon ) used in combination with anabolic steroids (retabolil) in patients with acute myocardial infarctions. Specific protein reparative therapy was associated with a favourable course of the disease, earlier (as against the control group) normalization of the electrotopocartographic (precordial mapping) and enzymic (CPK, LDH and LDH1) parameters. The patients' faster readaptation toward exercise and a significant elevation in the hemodynamic parameters justify the advisability of including protein reparative agents into the multiple modality treatment of myocardial infarction.
D000410:Alanine Transaminase / Q000097:blood; D000596:Amino Acids / Q000008:administration & dosage*; D001219:Aspartate Aminotransferases / Q000097:blood; D003402:Creatine Kinase / Q000097:blood; D004359:Drug Therapy, Combination; D004562:Electrocardiography; D005080:Exercise Test; D006801:Humans; D007527:Isoenzymes; D007770:L-Lactate Dehydrogenase / Q000097:blood; D009203:Myocardial Infarction / Q000188:drug therapy*; D009277:Nandrolone / Q000008:administration & dosage / Q000031:analogs & derivatives*; D000077603:Nandrolone Decanoate
D000596:Amino Acids; D007527:Isoenzymes; D009277:Nandrolone; D007770:L-Lactate Dehydrogenase; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D003402:Creatine Kinase; D000077603:Nandrolone Decanoate
Klinicheskaia éffektivnost' primeneniia aminokislotnykh preparatov v komplekse s anabolicheskimi steroidami s tsel'iu ogranicheniia razmerov infarkta miokarda.